Copyright © 2003 by the European Society of Cardiology.
Reply to Letter to the Editor
Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis
a Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
b Department of Public Health Sciences, St George's Hospital School of Medicine, London SW17 0RE, UK
c Department of Primary Care and Population Sciences, Royal Free UCL Medical School, London, UK
* Corresponding author. Tel.: +44-1223330-165; fax: +44-1223-330-330 (J. Danesh)
E-mail address: pwhincup{at}sghms.ac.uk
Received 14 October 2002; accepted 23 October 2002
Our synthesis of the available evidence from 10 long-term prospective studies in approximately general populations, involving a total of 2283 cases of non-fatal myocardial infarction or coronary heart disease death and 7143 controls, yielded a combined odds ratio of 1.25 (1.03–1.53) for coronary heart disease in individuals with higher concentrations of Chlamydia pneumoniae IgA titres.1 This estimate was not significantly different from the odds ratio of 1.15 (0.97–1.36) observed in a previous synthesis of 15 long-term prospective studies of C. pneumoniae IgG titres and coronary heart disease (
; 
).2 Hence, as stated in our report, the available prospective epidemiological information suggests that these markers of C. pneumoniae infection are not strongly predictive of coronary heart disease in general populations, but further data would be required to confirm or refute any weaker associations.
As with most other available prospective studies of C. pneumoniaeserological markers and coronary heart disease, data from the British Regional Heart Study (our contribution of new data to the meta-analysis) were analysed on a ‘nested’ case-control basis. In such analyses, individuals who develop disease (‘cases’) are compared with an appropriate subset of those who remain disease-free (‘controls’) in the same prospective cohort study. Such analyses are properly called ‘prospective’ studies because recruitment and collection of blood samples on which C. pneumoniaeexposure is based, as well as the ascertainment of potential confounding factors, have all occurred several years before the development of coronary heart disease outcomes. We measured C. pneumoniae IgA antibodies in more than 75% of the coronary heart disease cases known to emerge in British Regional Heart Study participants providing baseline blood samples. There was no important difference between these cases and those cases who did not have available blood samples for analysis, in terms of age at event, proportion of fatal vs. non-fataldisease, and other potentially relevant characteristics.
As stated in our report, to avoid potential biases arising from undue emphases on data from particular studies, we placed the C pneumoniae IgA findings from the British Regional Heart Study (which involved more coronary heart disease cases than all but one previous study) in the context of a meta-analysis of all other available long-term prospective studies. So, although data from the British Regional Heart Study were somewhat more positive than results from most previous prospective reports, there was no evidence of heterogeneity among the available studies (
; ).1 Similar considerations applied to our previous report of new data (and its accompanying meta-analysis) on C. pneumoniae IgG antibodies and coronary heart disease.2 Both instances reinforce the need to emphasise the totality of evidence rather than the results in one or another particular study. There is currently insufficient evidence to test Robert West's suggestion that serological markers of C. pneumoniae infection may be more strongly related to risk of coronary heart disease in women than in men.
References
- Danesh J, Whincup PH, Lewington S et al. Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2002;23:371–375.
[Abstract/Free Full Text] - Danesh J, Whincup PH, Walker M, Lennon L, Thomson A, Appleby P et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ. 2000;321:208–213.
[Abstract/Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. A. Barber, S. Hach, L. J. Tippett, L. Ross, A. F. Merry, and P. Milsom Cerebral Ischemic Lesions on Diffusion-Weighted Imaging Are Associated With Neurocognitive Decline After Cardiac Surgery Stroke, May 1, 2008; 39(5): 1427 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Antunes, L. Eugenio, J. Ferrao de Oliveira, and M. J. Antunes Mortality risk prediction in coronary surgery: a locally developed model outperforms external risk models Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 437 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nishida, M. Masuda, Y. Tomita, S. Tokunaga, Y. Tanoue, A. Shiose, S. Morita, and R. Tominaga The logistic EuroSCORE predicts the hospital mortality of the thoracic aortic surgery in consecutive 327 Japanese patients better than the additive EuroSCORE. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 578 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Biancari, O.-P. Kangasniemi, J. Luukkonen, S. Vuorisalo, J. Satta, R. Pokela, and T. Juvonen EuroSCORE predicts immediate and late outcome after coronary artery bypass surgery. Ann. Thorac. Surg., July 1, 2006; 82(1): 57 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Cornelissen and J. E Arrowsmith Preoperative assessment for cardiac surgery CEACCP, June 1, 2006; 6(3): 109 - 113. [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Yap, C. Reid, M. Yii, M. A. Rowland, M. Mohajeri, P. D. Skillington, S. Seevanayagam, and J. A. Smith Validation of the EuroSCORE model in Australia. Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 441 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Jin and G. L. Grunkemeier Does the logistic EuroSCORE offer an advantage over the additive model? Interactive CardioVascular and Thoracic Surgery, February 1, 2006; 5(1): 15 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Liistro, K. Ducci, G. Falsini, and L. Bolognese Early invasive strategy in elderly patients with non-ST-elevation acute coronary syndromes Eur. Heart J. Suppl., October 1, 2005; 7(suppl_K): K23 - K25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Liistro, P Angioli, G Falsini, K Ducci, S Baldassarre, A Burali, and L Bolognese Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome Heart, October 1, 2005; 91(10): 1284 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Leandro, N Rolando, G Gallus, K Rolles, and A K Burroughs Monitoring surgical and medical outcomes: the Bernoulli cumulative SUM chart. A novel application to assess clinical interventions Postgrad. Med. J., October 1, 2005; 81(960): 647 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kuss and J. Borgermann Prognoses from the logistic EuroSCORE are statistical estimates that require confidence intervals Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1129 - 1129. [Full Text] [PDF]
|
|
|
|
|
|
P. Michel, S. Domecq, L. R. Salmi, F. Roques, and S. A.M. Nashef Reply to Kuss and Borgermann: Confidence intervals for the prediction of mortality in the logistic EuroSCORE Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1129 - 1132. [Full Text] [PDF]
|
|
|
|
|
|
F. Collart, H. Feier, F. Kerbaul, A. Mouly-Bandini, A. Riberi, T. G. Mesana, and D. Metras Valvular surgery in octogenarians: operative risks factors, evaluation of Euroscore and long term results Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 276 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Toumpoulis, C. E. Anagnostopoulos, D. G. Swistel, and J. J. DeRose Jr Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery? Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 128 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sherlaw-Johnson, S. Gallivan, T. Treasure, and S.A.M. Nashef Computer tools to assist the monitoring of outcomes in surgery Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 1032 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A M Nashef and R. J F Baskett Quality Assessment in Cardiac Surgery: Do Not Miss the Boat! Asian Cardiovasc Thorac Ann, September 1, 2004; 12(3): 187 - 189. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Medalion, D. Meirson, E. Hauptman, L. Sasson, and A. Schachner Initial experience with the Heartstring proximal anastomotic system J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 273 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lassnigg, D. Schmidlin, M. Mouhieddine, L. M. Bachmann, W. Druml, P. Bauer, and M. Hiesmayr Minimal Changes of Serum Creatinine Predict Prognosis in Patients after Cardiothoracic Surgery: A Prospective Cohort Study J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1597 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Barmettler, F. F. Immer, P. A. Berdat, F. S. Eckstein, B. Kipfer, and T. P. Carrel Risk-stratification in thoracic aortic surgery: should the EuroSCORE be modified? Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 691 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Toumpoulis, C. E. Anagnostopoulos, J. J. DeRose, and D. G. Swistel European system for cardiac operative risk evaluation predicts long-term survival in patients with coronary artery bypass grafting Eur. J. Cardiothorac. Surg., January 1, 2004; 25(1): 51 - 58. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||